Cancers, Vol. 15, Pages 4470: Systematic Review of the Survival Outcomes of Neoadjuvant Chemotherapy in Women with Malignant Ovarian & mdash;An Germ Cell Tumors
In conclusion, NACT may be considered for the management of MOGCT; however, possible candidates for NACT use and an ideal number of NACT cycles remain unknown. Further studies are warranted to validate the efficacy of NACT in advanced MOGCT patients.
Source: Cancers - Category: Cancer & Oncology Authors: Hitomi Sakaguchi-Mukaida Shinya Matsuzaki Yutaka Ueda Satoko Matsuzaki Mamoru Kakuda Misooja Lee Satoki Deguchi Mina Sakata Michihide Maeda Reisa Kakubari Tsuyoshi Hisa Seiji Mabuchi Shoji Kamiura Tags: Systematic Review Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Clinical Trials | Epithelial Cancer | Germ Cell Tumors | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Ovarian Cancer | Ovaries | Serous Carcinoma | Study | Women